내부피폭 감시주기 및 섭취형태가 방사성핵종 섭취량 평가에 미치는 영향
방사성핵종의 특성, 섭취형태 그리고 내부피폭 감시주기는 작업자의 방사성핵종 섭취량 및 내부피폭선량 평가 결과에 중요한 영향을 줄 수 있다. 따라서 방사성핵종이 흡입섭취 될 경우 섭취형태(급성 또는 만성) 및 내부피폭 감시주기에 따른 섭취량 평가 오차를 계산하였다. 섭취 핵종으로는 /I(Type F), Cs(Type F), U(Type M, Type S)를 고려하였고, 방사능입자크기(AMAD)는 1 와 5 를 고려하였다. 섭취형태에 따라 평가된 섭취량의 상대오차는 방사성핵종, 흡수형태 그리고 내부피폭 감시주기에 따라 달랐으나, 입자크기에 의한 영향은 거의 없었다. 섭취형태 가정에 따른 섭취량 평가 오차를 10% 미만으로 줄일 수 있는 내부피폭 최대감시주기는 /I(Type F)에 대해 60일, Cs(Type F)에 대해 180일, U(Type M)에 대해 90일, 그리고 U(Type S)에 대해 360일로 나타났다.
A variety of factors such as the pattern of intake (acute or chronic), monitoring interval and the characteristics of the radionuclides could have a significant influence on the estimates for the intake and internal dose. The relative differences of the assessed intakes based on the assumption of an acute intake to that of a chronic intake were evaluated by using the predicted bioassay quantity in the whole body or organs for an acute and chronic intake through the inhalation of I, C, U with the AMAD of 1 and 5 for the monitoring intervals of 7, 14, 30, 60, 90, 120, 180, 360 days, respectively, The relative difference of the assessed intakes based on the intake pattern is affected by the monitoring interval, radionuclide and absorption type, but the particle size has little influence on the difference of the assessed intakes based on the intake pattern. The maximum monitoring interval, which is defined as the monitoring interval that the relative difference of the assessed intakes based on the assumption of an acute intake to that of a chronic intake is less than 10%, is 60 d for I with Type F, 180 d for C with Type F, 90 d for U with Type M, and 360 d for U with Type S. It was concluded that an intake pattern has little influence on the estimates of the assessed intake in the case where the monitoring interval is shorter than the maximum monitoring interval for each radionuclide.